EICHOR
● Terminated
Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.
Condition: Peripheral Arterial Disease · Diabetic Foot · Sponsor: Celularity Incorporated
About this study
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy and safety of intramuscular administration of human placenta-derived cells (PDA-002) in subjects with diabetic foot ulcers (DFU), including subjects with and without peripheral arterial disease (PAD). Subjects were randomized to receive one of three dose levels of PDA-002 or placebo. Randomization was stratified by PAD status. The study evaluated wound healing and safety outcomes over the follow-up period.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (45)
| Cardiology PC | Birmingham, Alabama, United States | — |
| Swagel wootoon hiatt eye center | Mesa, Arizona, United States | — |
| Carl T. Hayden Veterans Affairs Medical Center | Phoenix, Arizona, United States | — |
| Arizona Arthritis and Rheumatology Research, PLLC | Phoenix, Arizona, United States | — |
| NEA baptist clinic | Jonesboro, Arkansas, United States | — |
| Jeffrey A Klemes DPM | Beverly Hills, California, United States | — |
| Reliance Clinical Research | Chino, California, United States | — |
| Limb Preservation Platform, INC. | Fresno, California, United States | — |
| Foot and Ankle Clinic | Los Angeles, California, United States | — |
| VA Palo Alto Health Care System | Palo Alto, California, United States | — |
| Center for Clinical Research Inc. | San Francisco, California, United States | — |
| Stanford University | Stanford, California, United States | — |
+ 33 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02264288